sing 1% phenytoin ointment on the mucosa around the implant
Phase 3
Recruiting
- Conditions
- Examining the dimensions of the gingiva around the dental implant after using phenytoin ointment.
- Registration Number
- IRCT20211124053173N2
- Lead Sponsor
- Sanandaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Patients with one or more dental implants that reached to the impression stage
One type of dental implant system has been used for all patients
Exclusion Criteria
Smokers
People with a history of any systemic condition such as diabetes, etc,
Pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does 1% phenytoin ointment utilize to affect peri-implant mucosa in Phase III trials?
How does 1% phenytoin ointment compare to standard-of-care treatments for gingival dimensions around dental implants?
Are there specific biomarkers that predict response to phenytoin ointment in peri-implant mucosal therapy?
What are the potential adverse events associated with 1% phenytoin ointment on oral mucosa and their management strategies?
What related compounds or combination therapies are being explored for peri-implant mucosal health alongside phenytoin?